Radioimmunoassay Market Analysis, Market Dynamics and Regional Insights
- Get link
- X
- Other Apps
One of the most used in-vitro assay procedures for measuring antigen concentrations in blood is radioimmunoassay (RIA). The competitive binding assay is the basis for radioimmunoassay. Antibody and antigen bind to one another in this procedure, and the amount of bound antigen is evaluated using a radioimmunoassay. With the help of antibodies, this technology is hypersensitive and can detect even the tiniest amount of hormone or medication. Immunoassays are used to analyse a variety of clinical laboratory analytes, including nucleic acids, hormones, proteins, and medications. The development of more sensitive tests will lead to the discovery of novel biomarkers for illness diagnosis. Due to several characteristics such as specificity of results, accuracy, sensitivity, and precision, the importance of radioimmunoassay in the field of medical diagnostics has grown over time.
Radioimmunoassay Market – Dynamics
Due to the
increased frequency of different infectious diseases and cancer, the radioimmunoassay
market is expected to develop significantly over the forecast period.
According to the 2018 American Cancer Society report, cancer claimed the lives
of 609,640 people in the United States. Furthermore, the utilisation of
radioimmunoassay techniques in pharmaceutical enterprises, contract research
organisations, and research institutions is likely to fuel market expansion
throughout the forecast period. Other factors likely to fuel growth of the
radioimmunoassay market over the forecast period include rising need for
healthcare automation and high throughput operations in diagnostic laboratories
and research centres to ensure customer and patient satisfaction with
error-free results.
Radioimmunoassay Market – Regional
Insights
The
radioimmunoassay market is divided into North America, Europe, Latin America,
Asia Pacific, the Middle East, and Africa based on region. Because of increased
acceptance of technologically advanced equipment, public awareness, high
infection rates, improved medical facilities, and rising adoption of novel
goods, North America dominates the market. Furthermore, government assistance
for infection-free states is propelling the radioimmunoassay industry forward.
According to the National Ambulatory Medical Care Survey from 2015, there were
16.8 million visits to physician offices for infectious and parasitic
disorders.
- Get link
- X
- Other Apps
Comments
Post a Comment